CERVICURA Trademark

Trademark Overview


On Monday, April 20, 2015, a trademark application was filed for CERVICURA with the United States Patent and Trademark Office. The USPTO has given the CERVICURA trademark a serial number of 79166469. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 19, 2022. This trademark is owned by Genexine, Inc.. The CERVICURA trademark is filed in the Pharmaceutical Products category with the following description:

DNA vaccines; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; vaccines; antibiotics; anti-cancer preparations; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment...
cervicura

General Information


Serial Number79166469
Word MarkCERVICURA
Filing DateMonday, April 20, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 19, 2022
Registration Number4893999
Registration DateTuesday, February 2, 2016
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 17, 2015

Trademark Statements


Description of MarkThe mark consists of stylized letters "Cervicura".
Goods and ServicesDNA vaccines; Pharmaceutical products and preparations, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; vaccines; antibiotics; anti-cancer preparations; Drugs for medical purposes, namely, pharmaceutical drug preparations for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Injectable pharmaceuticals for medical purposes, namely, for the treatment and prevention of human papilloma virus infectious disease, cancer and cervical intraepithelial neoplasia; Cardiovascular pharmaceutical preparations for the treatment and prevention of heart and vascular diseases; Medicines for sensory organs, namely, pharmaceutical preparations for the prevention, treatment, and cure of diseases and conditions impacting the eyes, ears, nose, mouth and nervous system; Pharmaceutical preparations for digestive organs, namely, for the prevention, treatment, and cure of diseases and conditions impacting digestive organs; Dermatological pharmaceutical products; Blood solvent, namely, blood plasma, albumin, globulin, fibrinogen, thrombocyte and platelets; Pharmaceutical agents affecting metabolism; Anti-inflammatory preparations, namely, anti-inflammatory gels, ointments, salves, sprays, creams, pills, powders, granules, tablets, capsules, depots, suppository, syrup, tinctures and emulsion; Therapeutic vaccines; preventive vaccines; Pharmaceutical preparations for immunomodulatory purposes, namely, for the regulation of immune functions; Pharmaceutical preparations for the treatment of cervical cancer; Pharmaceutical preparations for the treatment of cervical intraepithelial neoplasia; pharmaceutical preparations for the treatment of cervical pre-cancer; Pharmaceutical preparations for the treatment of head and neck cancer; Pharmaceutical preparations for immunotherapy; pharmaceutical preparations for anticancer immunotherapy; Pharmaceutical preparations for gene therapy; antiviral agent against human papilloma virus; preventive vaccines against human papilloma virus infections
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 19, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGenexine, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressKR

Party NameGenexine, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressKR

Trademark Events


Event DateEvent Description
Saturday, June 17, 2023TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, May 24, 2023TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, May 24, 2023INVALIDATION PROCESSED
Wednesday, April 19, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, August 19, 2022CANCELLED SECTION 71
Tuesday, February 2, 2021COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, May 28, 2020NEW REPRESENTATIVE AT IB RECEIVED
Saturday, July 9, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, May 3, 2016FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, May 3, 2016FINAL DISPOSITION PROCESSED
Monday, May 2, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, February 2, 2016REGISTERED-PRINCIPAL REGISTER
Friday, November 20, 2015NOTIFICATION PROCESSED BY IB
Tuesday, November 17, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 17, 2015PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, November 4, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, October 28, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, October 15, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, October 14, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 13, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, October 13, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 6, 2015ASSIGNED TO LIE
Friday, September 18, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, September 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 28, 2015REFUSAL PROCESSED BY IB
Friday, August 7, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, August 7, 2015REFUSAL PROCESSED BY MPU
Friday, August 7, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, August 6, 2015NON-FINAL ACTION WRITTEN
Wednesday, July 29, 2015ASSIGNED TO EXAMINER
Saturday, June 13, 2015APPLICATION FILING RECEIPT MAILED
Tuesday, June 9, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 4, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB